New liposomal liver-specific contrast agent for CT: first human phase I clinical trial assessing efficacy and safety.
Leander
P
P
Department of Diagnostic Radiology, Malmö University Hospital, Lund University, Sweden.
Höglund
P
P
Kloster
Y
Y
Børseth
A
A
D003287:Contrast Media / Q000009:adverse effects; D005260:Female; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage*; D008099:Liver / Q000000981:diagnostic imaging*; D008297:Male; D014057:Tomography, X-Ray Computed; D014283:Triiodobenzoic Acids / Q000008:administration & dosage* / Q000009:adverse effects
D003287:Contrast Media; D008081:Liposomes; D014283:Triiodobenzoic Acids; C044834:iodixanol